|Mr. Anthony John Durkacz||Founder & Exec. Co-Chairman||N/A||N/A||1976|
|Dr. Raza Bokhari M.B.A., MBA||MD, Exec. Co-Chairman & CEO||1||N/A||1968|
|Mr. Zeeshan Saeed||Founder, Pres & Director||604.92k||N/A||1971|
|Mr. Donal Carroll CPA||Chief Financial Officer||58.67k||N/A||1977|
|Ms. Sandy Huard||Head of Communications & Investor Relation||N/A||N/A||N/A|
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Cobourg, Canada.
FSD Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.